마취 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Anesthesia Devices Market Summary

The global anesthesia devices market size was estimated at USD 24.6 billion in 2025 and is projected to reach USD 30.3 billion by 2033, growing at a CAGR of 2.26% from 2026 to 2033. The market growth is driven by the increasing number of surgical procedures worldwide, the prevalence of chronic diseases, and technological advancements in anesthesia workstations and monitors

Increasing frequency of new and upgraded product launches by leading manufacturers is accelerating technology adoption and replacement demand across hospitals and surgical centers, contributing to the growth of the anesthesia machines industry. Major players are continuously introducing next-generation anesthesia workstations with enhanced safety features, advanced ventilation modes, improved ergonomics, digital integration, and sustainability-focused designs, addressing evolving clinical requirements across adult, pediatric, and neonatal care. For instance:

• In October 2025, GE HealthCare launched the Carestation 850 anesthesia delivery system at ANESTHESIOLOGY 2025, featuring ergonomic design, customizable apps, advanced vaporization, sustainability tools, and intuitive UI to enhance precision and efficiency for diverse patients from neonates to adults.

"In the dynamic operating environment, anesthesia professionals are focused on safety while managing increasingly complex cases and changing patient needs. As anesthesia care teams face new challenges, technology can help ease the burden and support safer and more effective care delivery."

John Beard, MD, anesthesiologist and Chief Medical Officer of Patient Care Solutions at GE HealthCare.

• In September 2025, Medisys launched the Made-in-India COSMOS anesthesia workstation, featuring a 15-inch advanced interface, integrated patient monitoring, and neonatal technology such as LED Phototherapy, at Medicall Delhi. This launch prioritized patient safety, clinician usability, and eco-friendly efficiency.

Such continuous innovation expands the clinical applicability of anesthesia machines, supports compliance with stricter safety and efficiency standards, and encourages healthcare providers to upgrade legacy systems, thereby strongly driving overall market growth and long-term demand for advanced anesthesia workstations.

A significant emerging trend in the anesthesia devices market is the integration of artificial intelligence (AI) and smart software, which is transforming the delivery of anesthesia care. AI-enabled algorithms support intelligent ventilation management, optimize anesthetic gas delivery using real-time patient data, enable predictive alarms to anticipate adverse events, and reduce clinician cognitive burden through automation and decision support.

These capabilities also improve workflow efficiency, standardize care across adult, pediatric, and neonatal populations, and enhance interoperability with perioperative IT systems. For instance, in January 2026, GE HealthCare collaborated with NXP Semiconductors to develop edge AI solutions for acute care, including voice-activated anesthesia delivery systems to reduce clinician cognitive load and real-time neonatal monitoring for NICUs, showcased at CES 2026; the partnership leverages NXP's secure edge processors and GE HealthCare's medical technology expertise to deliver low-latency, privacy-focused AI in operating rooms and other high-acuity settings. Thus, the growing integration of AI is making anesthesia devices smarter, safer, and more efficient, thereby accelerating the adoption of advanced anesthesia systems across modern healthcare facilities.

Global Anesthesia Devices Market Report Segmentation

This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global anesthesia devices market report based on product, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Anesthesia Machines
  • Anesthesia Workstation
  • Anesthesia delivery machines
  • Portable
  • Standalone
  • Anesthesia Ventilators
  • Anesthesia Monitors
• Anesthesia Disposables
  • Anesthesia Masks
  • Anesthesia Accessories
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product outlook
  • 1.1.2. End Use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End Use
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Anesthesia Devices Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market Driver analysis
    • 3.1.1.1. Increasing number of surgical procedures worldwide
    • 3.1.1.2. Rising prevalence of chronic diseases requiring surgery
    • 3.1.1.3. Growth of ambulatory surgery and day-care centers
    • 3.1.1.4. Technological advancements in anesthesia workstations and monitors
  • 3.1.2. Market Restraint Analysis
    • 3.1.2.1. High capital cost of advanced anesthesia workstations
    • 3.1.2.2. High maintenance and servicing costs
  • 3.1.3. Market Opportunities
  • 3.1.4. Market Challenges
  • 3.1.5. Emerging Trends
• 3.2. Anesthesia Devices Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's
    • 3.2.1.1. Supplier power
    • 3.2.1.2. Buyer power
    • 3.2.1.3. Substitution threat
    • 3.2.1.4. Threat of new entrant
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental landscape
    • 3.2.2.6. Legal landscape

Chapter 4. Anesthesia Devices Market: Product Estimates & Trend Analysis

• 4.1. Product Type Market Share, 2025 & 2033
• 4.2. Segment Dashboard
• 4.3. Global Anesthesia Devices Market by Product Type Outlook
• 4.4. Anesthesia Machines
  • 4.4.1. Anesthesia Machines market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Anesthesia Workstation
    • 4.4.2.1. Anesthesia Workstation market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Anesthesia Delivery Machines
    • 4.4.3.1. Anesthesia Delivery Machines market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Portable Anesthesia Delivery Station
      • 4.4.3.2.1. Portable Anesthesia Delivery Machines market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.3. Standalone Anesthesia Delivery Station
      • 4.4.3.3.1. Standalone Anesthesia Delivery Machines market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Anesthesia Ventilators
    • 4.4.4.1. Anesthesia Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Anesthesia Monitors
    • 4.4.5.1. Anesthesia Monitors market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Anesthesia Disposables
  • 4.5.1. Anesthesia Disposables market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Anesthesia Masks
    • 4.5.2.1. Anesthesia Masks market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Anesthesia Accessories
    • 4.5.3.1. Anesthesia Accessories market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Anesthesia Devices Market: End Use Estimates & Trend Analysis

• 5.1. End Use Type Market Share, 2025 & 2033
• 5.2. Segment Dashboard
• 5.3. Global Anesthesia Devices Market by End Use Outlook
• 5.4. Hospitals
  • 5.4.1. Hospitals' market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Ambulatory Centers
  • 5.5.1. Ambulatory Centers market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Anesthesia Devices Market: Regional Estimates & Trend Analysis, By Product & End Use

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ reimbursement structure
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework/ reimbursement structure
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework/ reimbursement structure
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework/ reimbursement structure
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework/ reimbursement structure
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework/ reimbursement structure
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework/ reimbursement structure
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework/ reimbursement structure
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework/ reimbursement structure
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework/ reimbursement structure
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market share/position analysis, 2025
• 7.4. Company Profiles
  • 7.4.1. GE Healthcare
    • 7.4.1.1. Company Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Dragerwerk AG & Co. KGaA
    • 7.4.2.1. Company Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Mindray Bio-Medical Electronics Co., Ltd.
    • 7.4.3.1. Company Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Medtronic
    • 7.4.4.1. Company Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Koninklijke Philips N.V.
    • 7.4.5.1. Company Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Beijing Aeonmed Co., Ltd.
    • 7.4.6.1. Company Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Spacelabs Healthcare acquired by OSI Systems, Inc.
    • 7.4.7.1. Company Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Getinge AB
    • 7.4.8.1. Company Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Penlon
    • 7.4.9.1. Company Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Heal Force Bio-Meditech Holdings Limited
    • 7.4.10.1. Company Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. Shenzhen Northern Meditec Limited
    • 7.4.11.1. Company Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Shanghai Huifeng Medical Instrument Co., Ltd.
    • 7.4.12.1. Company Overview
    • 7.4.12.2. Financial Performance
    • 7.4.12.3. Product Benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Shenzhen Comen Medical Instruments Co., Ltd.
    • 7.4.13.1. Company Overview
    • 7.4.13.2. Financial Performance
    • 7.4.13.3. Product Benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. BPL Medical Technologies
    • 7.4.14.1. Company Overview
    • 7.4.14.2. Financial Performance
    • 7.4.14.3. Product Benchmarking
    • 7.4.14.4. Strategic initiatives
  • 7.4.15. aXcent medical
    • 7.4.15.1. Company Overview
    • 7.4.15.2. Financial Performance
    • 7.4.15.3. Product Benchmarking
    • 7.4.15.4. Strategic initiatives